Vasopeptidase inhibitors: an emerging class of cardiovascular drugs
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference26 articles.
1. Vasopeptidase inhibition: a new concept in blood pressure management;Burnett;J. Hypertens.,1999
2. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril;Gros;Proc. Natl. Acad. Sci. U. S. A.,1991
3. Neutral endopeptidase inhibitors and combined inhibitors of neutral endopeptidase and angiotensin-converting enzyme;Robl,1997
4. Recent advances in the development of dual angiotensin-converting enzyme and neutral endopeptidase inhibitors;Fink;Exp. Opin. Ther. Patents,1996
5. In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor;Azizi;Hypertension,2000
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ring-closing metathesis/transannular cyclization to azabicyclo[X.Y.0]alkanone dipeptide turn mimics for biomedical applications;Peptide and Peptidomimetic Therapeutics;2022
2. Angiotensin‐Converting Enzyme Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26
3. In silico based investigation of dynamic variations in neprilysin (NEP and NEP2) proteins for extracting the point of specificity;Molecular BioSystems;2016
4. Renin–Angiotensin System;Drug Discovery and Evaluation: Pharmacological Assays;2016
5. Renin–Angiotensin System;Drug Discovery and Evaluation: Pharmacological Assays;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3